相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of the effects of atazanavir-ritonavir on the pharmacokinetics of lumefantrine in patients living with HIV in Lagos University Teaching Hospital, South-Western Nigeria
Sikiru Olatunji Usman et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Effect of nevirapine, efavirenz and lopinavir/ritonavir on the therapeutic concentration and toxicity of lumefantrine in people living with HIV at Lagos University Teaching Hospital, Nigeria
Sikiru Olatunji Usman et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2020)
Evaluation of the effects on the QT-interval of 4 artemisinin-based combination therapies with a correction-free and heart rate-free method
Christian Funck-Brentano et al.
SCIENTIFIC REPORTS (2019)
CLINICALLY SIGNIFICANT DRUG-DRUG INTERACTION IN A LARGE ANTIRETROVIRAL TREATMENT CENTRE IN LAGOS, NIGERIA
I. A. Oreagba et al.
JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY (2019)
Malaria and HIV coinfection in sub-Saharan Africa: prevalence, impact, and treatment strategies
Tebit E. Kwenti
RESEARCH AND REPORTS IN TROPICAL MEDICINE (2018)
Effects of artemisinin antimalarials on Cytochrome P450 enzymes in vitro using recombinant enzymes and human liver microsomes: potential implications for combination therapies
Therese Ericsson et al.
XENOBIOTICA (2014)
Differential effects of clinically used derivatives and metabolites of artemisinin in the activation of constitutive androstane receptor isoforms
O. Burk et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adults
Pauline Byakika-Kibwika et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Antiretroviral Agents and Prevention of Malaria in HIV-Infected Ugandan Children
Jane Achan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Atazanavir/ritonavir-based combination antiretroviral therapy for treatment of HIV-1 infection in adults
Chad J. Achenbach et al.
FUTURE VIROLOGY (2011)
Outcomes of switch to atazanavir-containing combination antiretroviral therapy in HIV-1-infected patients with hyperlipidemia
Ching-Lan Lu et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2011)
Change to atazanavir/ritonavir treatment improves lipids but not endothelial function in patients on stable antiretroviral therapy
Robert L. Murphy et al.
AIDS (2010)
Relationship between HIV protease inhibitors and QTc interval duration in HIV-infected patients: a cross-sectional study
Beny Charbit et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Fatal cardiotoxicity related to halofantrine: a review based on a worldwide safety data base
Olivier Bouchaud et al.
MALARIA JOURNAL (2009)
Prolonged QT interval and Torsades de Pointes associated with atazanavir therapy
Tam Ly et al.
CLINICAL INFECTIOUS DISEASES (2007)
Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity:: demonstrable differences in vitro and clinically
Mustafa A. Noor et al.
AIDS (2006)
HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy
J Röling et al.
CLINICAL INFECTIOUS DISEASES (2006)
Body fat and other metabolic effects of atazanavir and efavirenz, each administered in combination with zidovudine plus lamivudine, in antiretroviral-naive HIV-infected patients
JG Jemsek et al.
CLINICAL INFECTIOUS DISEASES (2006)
Atazanavir: Effects on P-glycoprotein transport and CYP3A metabolism in vitro
ES Perloff et al.
DRUG METABOLISM AND DISPOSITION (2005)
Cross-resistance patterns among HIV protease inhibitors
M Kozal
AIDS PATIENT CARE AND STDS (2004)
Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study
J Whitworth et al.
LANCET (2000)
Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria
F Ezzet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
